References
- Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, et al. The burden of selected digestive disease in the United States. Gastroenterology 2002;122:1500–11.
- Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998;42:690–5.
- Mantynen T, Farkkila M, Kunnamo I, Mecklin JP, Juhola M, Voutilainen M. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: A 1-year cross-sectional study in a referral area with 260,000 inhabitants. Am J Gastroenterol 2002;97:2524–9.
- el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngealor pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997;113:755–60.
- Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
- Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21:953–6.
- Heading RC. Prevalence of upper gastrointestinal symptoms in the general population: a systematic review. Scand J Gastroenterol 1999;34 Suppl 231:3–8.
- Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992;51 Suppl 1:24–9.
- Dent J. Definitions of reflux disease and its separation from dyspepsia. Gut 2002;50:iv17-iv20.
- Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–80.
- Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996;110:1982–96.
- Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. Oxford, New York: Oxford University Press; 1995. p. 85–8.
- Norusis MJ. SPSS 10.0. Chicago IL: SPSS Inc.; 1999.
- Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999; 72:81–92.
- Dhiman RK, Saraswat VA, Naik SR. Ambulatory esophageal pH monitoring. Technique, interpretations and clinical indications. Dig Dis Sci 2002;47:241–50.
- Johnsson F, Solhaug WJ-H, Hernqvist H, Bengtsson L. One-week omeprazole treatment in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:15–30.
- Fass R, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE, et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999; 159: 2161–8.
- Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesphageal reflux disease. Scand J Gastroenterol 1998;33:1023–9.
- Ofman JJ, Shaw M, Sadik K, Grogg A, Emery K, Lee J, et al. Identifying patients with gastroesophageal reflux disease: validation of a practical screening tool. Dig Dis Sci 2002; 47: 1863–9.
- Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96: 52–7.
- Manterola C, Muüoz S, Grande L, Bustos L. Initial validation of a questionnaire for detecting gastroesophageal reflux disease in epidemiological settings. J Clin Epidemiol 2002;55:1041–5.
- Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;8683:205–8.
- Kahrilas PJ, Pandolfino JE. Gastroesophageal reflux disease and its complications, including Barrett’s metaplasia. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran’s gastrointestinal and liver diseases. 7th ed. Philadelphia: Saunders; 2002. p. 609–10.